| Description | Racemetirosine is a Tyrosine 3-monooxygenase inhibitor, and inhibits the synthesis of catecholamines consequently. |
| molecular weight | 195.22 |
| Molecular formula | C10H13NO3 |
| CAS | 658-48-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: Slightly soluble |
| References | 1. Khakimova GR, et al. "Provocation test" as a novel approach to early diagnosis of Parkinson's disease. Dokl Biol Sci. 2015;460:17-9. 2. Caravaggio F, et al. Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humans. Int J Neuropsychopharmacol. 2015 Feb 25;18(7):pyv014. 3. Caravaggio F, et al. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO. Neuropsychopharmacology. 2014 Nov;39(12):2769-76. 4. Homan P, Drevets WC, Hasler G. The effects of catecholamine depletion on the neural response to fearful faces in remitted depression. Int J Neuropsychopharmacol. 2014 Sep;17(9):1419-28. |